Reader Login| Users Online: 2116  
Home Print this page Email this page Small font sizeDefault font sizeIncrease font size   
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contact us
Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2000| September-November  | Volume 1 | Issue 9  
    Online since April 13, 2018

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
Fetal Arrythmias
Andrej Robida
September-November 2000, 1(9):358-364
As many as 20% of referrals for fetal echocardiography is due to fetal arrhythmias. They may occur in 2% of pregnancies. Indication for echocardiographic evaluation of heart rhythm are sustained fetal heart rate below 100 beats per minute, sustained heart rates above 180 beats per minute, unexplained hydrops fetalis, and frequent and repetitive irregular heart beats. Fetuses with either sustained bradycardia or tachycardia deserve expeditious evaluation. The most important fetal bradycardia is a complete atrioventricular block, which can be associated with a structural heart disease or occur as a consequence of maternal collagen vascular disease and/ or lupus associated antibodies. Fetal therapy is difficult and often unsuccessful. The most common serious fetal tachycardia is orthodromic reciprocating atrioventricular tachycardia followed by atrial flutter. These tachycardias can be treated in utero and proposed protocols for drug management are described. A close fetal and maternal monitoring during treatment and a team approach is advised.
[ABSTRACT]   Full text not available  [PDF]
  738 67 -
Alcohol: Friend or foe? A historical perspective
Rachel Hajar
September-November 2000, 1(9):341-344
Full text not available  [PDF]
  735 66 -
Catheter treatment of hypertrophic obstructive cardiomyopathy
Ulrich Sigwart, Rod Stables
September-November 2000, 1(9):334-340
Non-surgical septal reduction (NSSR) is a promising new therapy for the treatment of classical hypertrophic obstructive cardiomyopathy (HOCM). Patients should have symptoms related to a significant left ventricular outflow tract gradient. The procedure involves the selective injection of absolute alcohol into the hypertrophied basal septum via the epicardial coronary vessels. This results in localized infarction with septal thinning and the other changes that tend to reduce the LVOT gradient. The procedure is well tolerated with low mortality. The principal complication is the development of heart block, which demands pacemaker implantation in around 20% of patients. Hemodynamic and functional improvement may take some time to become evident and improvement may continue for several months after the procedure. Emerging medium-term follow-up data suggest that the benefits are sustained with no late morbidity. The long-term outcome of the procedure is not known and its value has never been compared to other therapeutic options in randomized controlled trials.
[ABSTRACT]   Full text not available  [PDF]
  742 53 -
Evidence based strategy of coronary revascularization: The answer to the paradigm shift in the treatment of chronic coronary artery disease
Yukihiro Kaneko, Werner Mohl
September-November 2000, 1(9):345-353
The choice of treatment strategy from medical therapy, percutaneous transluminal coronary angioplasty (PTCA), and coronary artery bypass grafting (CABG) greatly influences outcome of patients with chronic coronary artery disease. Recent randomized trials and registries provide information as to the judgment of optimal treatment strategy. These studies have shown that best outcome is likely when 1- or 2- vessel disease without proximal left anterior descending artery (LAD) stenosis is treated medically. 2-vessel disease with proximal LAD stenosis or 3-vessel disease without proximal LAD stenosis is treated by PTCA or CABG. 3-vessel disease with proximal LAD stenosis or left main coronary stenosis is treated by CABG. CABG is preferred to PTCA in diabetic patients and patients with decreased left ventricular function. Recent advances in the treatment of coronary artery disease are also reviewed as they influence current treatment strategy.
[ABSTRACT]   Full text not available  [PDF]
  706 53 -
Disappearance of left bundle branch block in a patient with refractory unstable angina after abciximab therapy
Gianluca Di Micco, Aniello Ascione, Paolo de Campora, Maurizio D'Ambrosio, Raffaele Sangiuolo, Vincenzo Sepe
September-November 2000, 1(9):354-357
Full text not available  [PDF]
  569 56 -
Cardiovascular News

September-November 2000, 1(9):332-333
Full text not available  [PDF]
  505 56 -
Greek and roman surgical instruments

September-November 2000, 1(9):366-369
Full text not available  [PDF]
  478 54 -
Coil occlusion of residual patent ductus arteriosus after rashkind umbrella
Vikas Kholi
September-November 2000, 1(9):365-365
Full text not available  [PDF]
  455 64 -
Echocardiography statistics in hamad medical corporation

September-November 2000, 1(9):378-378
Full text not available  [PDF]
  409 59 -
Tachyarrythmias following coronary artery bypass grafting
Bernard E F Hockings
September-November 2000, 1(9):379-379
Full text not available  [PDF]
  392 59 -
Anomalous left coronary artery from the pulmonary artery
Vikas Kohli
September-November 2000, 1(9):379-380
Full text not available  [PDF]
  375 49 -
The cave man's art
Rachel Hajar
September-November 2000, 1(9):370-374
Full text not available  [PDF]
  366 56 -
Heart rate variability follow-ing myocardial infarction
JC Davidson
September-November 2000, 1(9):380-380
Full text not available  [PDF]
  368 47 -
Chairman's Reflections
Hajar A Hajar
September-November 2000, 1(9):375-377
Full text not available  [PDF]
  320 59 -